We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Psychedelics

What Is the Best Approach to Psychedelic Therapy? An Interview With Field Trip’s Ronan Levy

Technology Networks spoke to the co-founder of Field Trip Health, a Toronto-based provider of ketamine therapy, on why 2021 was such a significant year for psychedelics.

Read More

Awakn’s Ketamine-gambling Disorder Study Expands to Test Whether the Drug Can Also Treat Binge Eating

The company behind the trial has expanded it to include three other behavioral addictions: binge eating disorder, compulsive sexual behavior and internet gaming disorder.

Read More

Quality Testing for Psychedelic Drugs

To date, no classical psychedelic agents have been approved for use as a medicine but what does convention tell us about the way these drugs will be scrutinized and assessed for quality?

Read More

A History of LSD: Discovery, the Law and Clinical Research

Stephen Wright reviews the status of pre-clinical and clinical research into the use of LSD to treat a range of conditions and provide insights into the future of research involving this drug.

Read More

Psilocybin Is Safe to Use in 10mg and 25mg Doses, Study Finds

The researchers came to their conclusion after providing the drug to participants of a controlled trial of psilocybin-mediated therapy.

Read More

The Top 10 Cannabis Stories of 2021

The year posed many challenges, but cannabis businesses, research centers, and reform groups still managed to make impressive headway. Analytical Cannabis looks back on the stories and issues that dominated the cannabis industry in 2021.

Read More

Mental Health Benefits of Ayahuasca Ceremonies May Be Due to a Placebo Effect, Study Finds

Participants in ayahuasca ceremonies report reductions in stress, anxiety, and depression whether they are given ayahuasca or not, a placebo-controlled study from researchers at Maastricht University has found.

Read More

Single Dose of Psychedelic Triggers Long-Lasting Changes in Mouse Brain Connectivity

These epigenetic changes may help to explain the long-lasting improvements to mental health identified in other recent psychedelic research projects.

Read More

More People Are Microdosing Psychedelics, World Drug Survey Finds

Around the world, it seems people are microdosing psychedelics more, and consuming other drugs like cocaine, alcohol, and cannabis less.

Read More

 
Advertisement